Cargando…

Effectiveness of Mycophenolate Mofetil in the Treatment of Pediatric Anti-NMDAR Encephalitis: A Retrospective Analysis of 6 Cases

Objective: To explore the effectiveness and safety of mycophenolate mofetil (MMF) as a second-line medication in the treatment of anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis, the most common and severe autoimmune encephalitis. Methods: The clinical data of six children with anti-NMDAR en...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hao, Xiao-sheng, Wang, Jiang-tao, Chen, Chen, Hao, Yun-peng, Liang, Jian-min, Liu, Song-yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7680875/ https://www.ncbi.nlm.nih.gov/pubmed/33240207 http://dx.doi.org/10.3389/fneur.2020.584446

Ejemplares similares

Corrigendum: Effectiveness of mycophenolate mofetil in the treatment of pediatric anti-NMDAR encephalitis: A retrospective analysis of 6 cases
por: Hao, Xiao-sheng, et al.
Publicado: (2023)

Thyroid Function and Anti-thyroid Antibodies in Pediatric Anti-NMDAR Encephalitis
por: Chen, Lianfeng, et al.
Publicado: (2021)

Neuronal NMDAR Currents of the Hippocampus and Learning Performance in Autoimmune Anti-NMDAR Encephalitis and Involvement of TNF-α and IL-6
por: Wang, Xu, et al.
Publicado: (2019)

Concurrent Tuberculous Meningoencephalitis and Anti-NMDAR Encephalitis: A Case Report
por: Xiaoli, Chen, et al.
Publicado: (2022)

Clinical Characteristics and Follow-Up of Seizures in Children With Anti-NMDAR Encephalitis
por: Zhang, Jianzhao, et al.
Publicado: (2022)

Efficacy and Safety of Rituximab in Chinese Children With Refractory Anti-NMDAR Encephalitis
por: Dou, Xiangjun, et al.
Publicado: (2020)

Intracranial Hemorrhage Associated With Listeria monocytogenes Bacteremia in an Elderly Patient on Mycophenolate Mofetil
por: Alammora, Abdelkarim, et al.
Publicado: (2022)

Toxoplasmic encephalitis during mycophenolate mofetil immunotherapy of neuromuscular disease
por: Bernardo, Danilo R., et al.
Publicado: (2015)

Presence of anti-nuclear antibody associated with worse clinical outcomes of anti-NMDAR encephalitis
por: Lei, Chunyan, et al.
Publicado: (2022)

Elevation of YKL-40 in the CSF of Anti-NMDAR Encephalitis Patients Is Associated With Poor Prognosis
por: Chen, Jinyu, et al.
Publicado: (2018)

Novel Object Recognition in Rats With NMDAR Dysfunction in CA1 After Stereotactic Injection of Anti-NMDAR Encephalitis Cerebrospinal Fluid
por: Kersten, Maxi, et al.
Publicado: (2019)

Molecular Pathogenesis of Anti-NMDAR Encephalitis
por: Ding, Hao, et al.
Publicado: (2015)

Extreme Delta Brush in Anti-NMDAR Encephalitis Correlates With Poor Functional Outcome and Death
por: Nathoo, Nabeela, et al.
Publicado: (2021)

Two Cases of Late-Onset Anti-NMDAr Auto-Immune Encephalitis After Herpes Simplex Virus 1 Encephalitis
por: Dorcet, Guillaume, et al.
Publicado: (2020)

Case Report: Anti-NMDAR Encephalitis With Anti-MOG CNS Demyelination After Recurrent CNS Demyelination
por: Ren, Bing-Yan, et al.
Publicado: (2021)

Case Report: Triphasic Waves in a 9-Year-Old Girl With Anti-NMDAR Encephalitis
por: Zhang, Ke, et al.
Publicado: (2022)

Comparison of Long-Term Use of Low Dose Rituximab and Mycophenolate Mofetil in Chinese Patients With Neuromyelitis Optica Spectrum Disorder
por: Lin, Jie, et al.
Publicado: (2022)

Comparison of Renal Responses Between Continuous Mycophenolate Mofetil and Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Lupus Nephritis
por: Liao, Yu-Wan, et al.
Publicado: (2022)

Clinical Features, Treatment, and Outcomes Among Chinese Children With Anti-methyl-D-aspartate Receptor (Anti-NMDAR) Encephalitis
por: Zhang, Min, et al.
Publicado: (2019)

Efficacy and tolerability of mycophenolate mofetil in a pediatric Rasmussen syndrome()
por: Orsini, A., et al.
Publicado: (2019)

Clinical Features of Coexisting Anti-NMDAR and MOG Antibody-Associated Encephalitis: A Systematic Review and Meta-Analysis
por: Ding, Jiayue, et al.
Publicado: (2021)

Population pharmacokinetics of mycophenolate mofetil in pediatric patients early after liver transplantation
por: Wei, Yinyi, et al.
Publicado: (2022)

Mycophenolate mofetil in the treatment of lupus nephritis
por: Yong, Patrick FK, et al.
Publicado: (2008)

Severe Enteropathy From Mycophenolate Mofetil
por: Jehangir, Asad, et al.
Publicado: (2016)

Autoimmune Gastritis Treated With Mycophenolate Mofetil
por: Harb, Ali H., et al.
Publicado: (2020)

Mycophenolate mofetil: Cytopenia: case report
Publicado: (2021)

Mycophenolate mofetil in giant cell arteritis
por: Pankow, Anne, et al.
Publicado: (2023)

“Everyone Thought She Was Crazy”: A Report on a Novel Approach to Diagnosing a Case of Anti-NMDAR Encephalitis
por: Martinez, Ricardo, et al.
Publicado: (2022)

Prodromal headache in anti‐NMDAR encephalitis: An epiphenomenon of NMDAR autoimmunity
por: Tominaga, Naomi, et al.
Publicado: (2018)

Features and Prognostic Value of Quantitative Electroencephalogram Changes in Critically Ill and Non-critically Ill Anti-NMDAR Encephalitis Patients: A Pilot Study
por: Jiang, Nan, et al.
Publicado: (2018)

Case Report: Rituximab Improved Epileptic Spasms and EEG Abnormalities in an Infant With West Syndrome and Anti-NMDAR Encephalitis Associated With APECED
por: Kawano, Go, et al.
Publicado: (2021)

Mycophenolate-mofetil/mycophenolic-acid: COVID-19: 4 case reports
Publicado: (2021)

Mycophenolate mofetil alters the antioxidant status in duodenum of rats: Implication for silymarin usage in mycophenolate mofetil-induced gastrointestinal disorders
por: Sheikhzadeh, Sanaz, et al.
Publicado: (2013)

The Chinese experience with anti-NMDAR encephalitis
por: Desestret, Virginie
Publicado: (2020)

Psychiatric manifestations of anti-NMDAR encephalitis
por: Martins, D., et al.
Publicado: (2021)

Anti-NMDAR encephalitis for psychiatrists: the essentials
por: Beattie, Matthew, et al.
Publicado: (2022)

Long-term neuropsychological outcome following pediatric anti-NMDAR encephalitis
por: de Bruijn, Marienke A.A.M., et al.
Publicado: (2018)

MANAGEMENT OF ERYTHEMA NODOSUM LEPROSUM BY MYCOPHENOLATE MOFETIL
por: Banerjee, Kalyan, et al.
Publicado: (2008)

Perforated Jejunal Diverticulum in the Use of Mycophenolate Mofetil
por: Thongprayoon, Charat, et al.
Publicado: (2014)

Mycophenolate mofetil as an alternative treatment for autoimmune hepatitis
por: Park, Seung Woon, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_89shc9lrl97gcepcecqd0elnsj